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ABSTRACT
Psoriasis is a chronic and recurrent inflammation skin disease characterized with hyperproliferation of keratinocyte
mediated by T cell lymphocytes. Climatotherapy (bathing and sunbathing) at Dead Sea is model therapy which is
effective for moderate and severe psoriasis. However there are group of psoriasis patients who are not responsive
to climatotherapy. The success of the model therapy was based on the influence of ultraviolet irradiation which
causes depletion of lymphocytes, macrophages, and dendritic cells of the skin. Patients who are not respond to
climatotherapy shown to have higher level of mangan (Mn) and lithium (Li) serum than responsive patients. Mangan
and Li were suspected influenced the viability of peripheral blood mononuclear cells (PBMC). The aim of the study is
to evaluate the effect of Mn and Li levels on the viability of PBMC in the serum of psoriasis patient after exposure
of narrowband UVB (NB-UVB). The PBMC were isolated from 6 psoriasis patients using Histopaque. Then the cells
isolate was incubated in RPMI medium with 0.02 to 0.08 µmol/L Mn and 0.08 to 0.1 µmol/L Li for 3 days. After that
the cells were irradiated once with 1/3 to 2 minimal erythem dose (MED) of NB-UVB. The PBMC viability was
measured 3 hours after irradiation with MTT assay and read with ELISA plate reader. The results showed that
increased levels of Mn and Li or combination did not affect on the viability of PBMC at 1/3 to 1 MED UV-UVB. But
at higher irradiation dose (2 MED), the higher level of Mn and Li had negative affect in the viability of PBMC after
irradiation. It could be concluded that the Mn and Li level in the serum did not affect the viability of PBMC after
irradiation of NB-UVB. It was suggest that other cellular component that involved in the development of psoriasis
lesions, such as dendritic cells, fibroblasts, macrophages, and keratinocyte, were associated with Mn and Li levels.
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INTRODUCTION
Psoriasis is a recurrent chronic skin disease,
mediated especially by lymphocyte T cell.1 The role
of Lymphocyte T cell is activated an epidermal
abnormality that specific for psoriasis.2 It was proved
by expression of cutaneous lymphocyte-associated
antigen (CLA) in lymphocyte cell which is homing in
the skin starting skin lesion in psoriasis.3
The management of psoriasis still becomes a
challenge because there was no therapeutic modality
which is effective to prevent reccurency.4 Climato-
therapy isa therapeuticmodality thatcombinedbathing
in sea water therapy with sun bathing.5 Until now,
Climatotherapy is an effective and safe alternative
therapy for psoriasis.6,7
Balneophototherapy isanartificial climatotherapy,
acombination of bathing in high concentrate salt water
with an artificial UV light like narrowband ultraviolet
B (NB-UVB).8Balneophototherapy has been reported
as an effective therapy for psoriasis vulgaris with
minimal side effect.9,10 The success of this therapy
model based on the effect of ultraviolet light irradiation
that induced lymphocyte, macrophage and skin
dendritic cell depletion.11 The effect of bathing in salt
water before phototherapy is effect of immune-
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modulated, anti inflammation and anti proliferative
because of the highly mineral concentration, releasing
of inflammation mediator like leukocyte elastase and
cytokine, water that penetrated in to stratum conium
will cause increases transmition of UVB.12
The culture of lymphocyte T which is homing
in the skin lesion of psoriasis showing increases of





was 0.85.13 In the periphery blood of psoriasis
patient there was an increased expression of CLA
because of lymphocyte T cell migration from





+ connected positively with
the severity of the disease.3 The exposure of
narrowband UVB could decreased the viability of
periphery blood mononuclear cell by activating an
apoptosis mechanism.14 In the unresponsive patient
with climatotherapy proofed to have higher level of
serum Mn and Li compare to responsive patient.
This because serum Mn reflect a manganese
superoxide dismutase activity in psoriasis skin lesion,
an enzyme which playing role in the cell
differentiation and proliferation. This enzyme
suspected played a role in increases of periphery
blood mononuclear cell, particularly T lymphocyte.
Thus although exposed with UVB, the mechanism
of activation cell apoptosis did not happened15. While
Li play a role in the early stage and in psoriasis
exacerbation.
MATERIALS AND METHODS
This research is an in vitro study, using simple
experimental research method. Subject inclusion
criteria were men or women with moderate to severe
grade of psoriasis, willing to follow the research and
sign for informed consent. Subject exclusion criteria
were an erythrodermic psoriasis patient, generalized
pustular psoriasis and psoriatic arthritis having
systemic therapy and phototherapy unless willing
to stop the therapy for 2 weeks before research,
pregnant and lactated.
Venous peripheral blood as much as 20 mL
was taken from the research subjects. Then the
PBMCs were isolated using Histopaque. The layers
which were formed after centrifugation, from
bottom to top, were erythrocyte, Histopaque,
lymphocyte and plasma. Lymphocyte layer which
formed cloudy ring then taken by pipette and
separated from sterile tube.
The lymphocyte cells that deposited at the
bottom of the tube were added with 1 mL complete
RPMI media (10% FBS add with 100 units/mL
penicillin, streptomycin 2%, PHA 50 µg/mL and
fungizone 0.5%) then mixed by pipette until become
a suspension of lymphocyte cell.
Next step was to put 100 µL of lymphocyte
cell suspension at each wheel, thus each wheel
contain of 2 x 105 cells. Then, Mn and Li were
added with concentration as follows Mn1 0.02 µmol/
L; Mn2 0.05 µmol/L; and Mn3 0,08 ìmol/L; Li1
0.08 µmol/L; Li2 0.09 µmol/L; and Li3 0.1 µmol/L
also combination of Mn1+Li1, Mn2+Li2, and
Mn3+Li3 according to research design.
Then the specimen was exposed with many
dose of sub MED narrow band UVB by TL-01
(311-312 nm) lamp. The doses were as followed
150, 200, 250, 500, and 1000 mJ/cm2. Finally the
viability of PBMC was counted by MTT assay and
read by ELISA reader 550 nm.
RESULTS AND DISCUSSION
The subject were 5 psoriasis patient with
moderate to severe degree of severity, consisted of
4 women (80%) and 1 man (20%). Their average
age were 43 ± 9 years old, the youngest was 29
years old while the oldest was 60 years old.
Peripheral blood mononuclear cells from those five
subjects was doubled at 96 well plates, therefore
the case and control group’s sample became 12 for
each treatment.
The result showed that there were no significant
differences in the viability of PBMC that was added
with Mn, Li and Mn plus Li in all concentration
compare with control (p>0.05) after exposure of
150, 200, 250 and 500 mJ/cm2 NB-UVB. The
differences became significant in the treated of Mn3
and Li1 at 1000 mJ/cm2 NB-UVB (TABLE 1).
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TABLE 1. The average of PBMC viability and p value after the addition of PBMC with Mn, Li, Mn + Li in different concentration
and exposure of 150, 200, 250, 500, and 1000 mJ/cm2 NB-UVB
The average of PBMC viability (p)
Doses of NB- UVB
(mJ/cm2) 150 200 250 500 1000
Mn1 0,741 (0,977) 0,694 (0,817) 0,678 (0,908) 0,231 (0,127) 0,249 (0,275)
Mn2 0,805 (0,544) 0,687 (0,773) 0,678 (0,817) 0,193 (0,050) 0,182 (0,050)
Mn3 0,735 (0,564) 0,651 (0,236) 0,632 (0,453) 0,244 (0,827) 0,184 (0,045)
Li1 0,779 (0,665) 0,670 (0,371) 0,638 (0,386) 0,170 (0,050) 0,184 (0,046)
Li2 0,776 (0,908) 0,644 (0,214) 0,647 (0,773) 0,179 (0,050) 0,206 (0,127)
Li3 0,772 (0,817) 0,665 (0,686) 0,647 (0,564) 0,179 (0,050) 0,189 (0,050)
MnLi1 0,762 (1,000) 0,674 (0,544) 0,660 (0,603) 0,206 (0,050) 0,206 (0,050)
MnLi2 0,789 (0,773) 0,709 (0,862) 0,675 (0,885) 0,195 (0,127) 0,174 (0,050)
MnLi3 0,809 (0,817) 0,660 (0,371) 0,652 (0,603) 0,135 (0,050) 0,154 (0,050)
Control 0,777 0,696 0,679 0,267 0,265
Because of there were no significant differences
of the average at the exposure of 100, 150, 200,
250 mJ/cm 2 NB-UVB, then the doses were
increased to 500 mJ/cm 2 and 1000 mJ/cm2.
Peripheral blood mononuclear from a subject were
doubled with 96 well plates, therefore became 3
sample in case and control groups. The control group
without exposure of 500 mJ/cm2 and 1000 mJ/cm2
NB - UVB were compared with control group with
exposure. The result showed a decreased in the
PBMC viability in the NB-UVB exposed group,
even not significantly different (FIGURE 1).
FIGURE 1. Graphic of the average of PBMC viability
without exposure of 500 and 1000 mJ/cm2
doses of NB –UVB
The result showed that there were a decrease in
the viability of PBMC which was added with the
different concentration of Mn, Li, Mn + Li compared
to control group, after exposure of 500 and 1000 mJ/
FIGURE 2. Graphic of the average of viability PBMC which
add with Mn in different concentration and exposure of 500
and 1000 mJ/cm2 NB –UVB
cm2 NB – UVB, but not significantly different unless
in the group adding with Mn3 (0.08L concentration)
and Li1 (0.08 L concentration) and exposure of
1000mJ/cm2 NB-UVB (FIGURE 2 and 3).
FIGURE 3. Graphic of the average of viability PBMC which
add with Li in different concentration and exposure of 500
and 1000 mJ/cm2 doses of NB –UVB
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The result showed that there were no effects
on the PBMC viability after the addition of different
concentration of Mn, Li, Mn + Li in and exposure
of 150, 200, and 250 mJ/cm2 NB – UVB. At dose
of NB-UVB reach 1000 mJ/cm2, there was a
decreasing of PBMC viability, but not significantly
different. The factors that could influence the result
were concentration of Mn, Li, Mn + Li, doses of
exposure and other mechanism that might be
involved in phototherapy response of psoriasis lesion
healing process.
The concentration of Mn and Li that were used
in this research were based on the research of
climatotherapy at Dead Sea. Serum Mn of psoriasis
patients who were responsive to climatotherapy was
0.02 ± 0.02 µmol/L, while in unresponsive patient
the concentration was 0.08 ± 0.03 µmol/L. Serum
Li of responsive psoriasis patients with
climatotherapy was 0.08 ± 0.03 µmol/L, while in
unresponsive patient the concentration was 0.1 ±
0.03 µmol/L.15 Those concentration were used as
baseline which were expected as the limit
concentration that might influenced the PBMC
viability. The concentration of Mn and Li that higher
than in the psoriasis patients serum were not used
due to no information its effect on PBMC viability.
Peripheral blood mononuclear cell exposed to
NB – UVB at 60, 180, and 360 mJ/cm2 dose, has
been proved could induce caspase activity that
depend on the dose and duration of the exposure.
An exposure of NB-UVB at 180mj/cm2 could
activate an apoptosis of PBMC.14 This research
proved that exposure of NB – UVB at 500 and
1000 mJ/cm2 could decrease PBMC viability even
though not significantly different.
According to the reference, psoriasis patients
who are unresponsive to climatotherapy has been
proved have hingher serum level of Mn and Li than
patient who responsive to climatotherapy.15 But this
research which was specific for PBMC psoriasis
patient showed that addition of different
concentration of Mn, Li, Mn + Li and exposure of
NB – UVB 1000mJ/cm2 tend to decrease the cell
viability.
This research proved that Li did not influence
PBMC viability in psoriasis patients. Therefore, it
was suspected that there was other role, in early
stage and in exacerbation of psoriasis that was
through inositol pathway of adenylate cyclase
system by decreasing cyclic adenosine
monophosphate (cAMP) and inositol then calcium
intercellular become decrease.15 This decreasing
made keratinocyte proliferation increase,
chemotaktic and leukocyte polimononuclear
increase and releasing of cytokine proinflamation.16
Releasing cytokine activation in psoriasis lesion was
very complex; also there was an indication that
releasing of cytokine not only in lymphocyte cell;
but the cytokine also stimulated the neighbourhood
cell like dendrite cell, macrophage and keratinocyte
to release more cytokine.18
Lithium was proved could influence keratino-
cyte cell at basal layer to proliferate, increased mitosis
cell speed and intercellular oedema.19 Lithium
stimulate neutrophyl cell of psoriasis patient to
release inflammatory mediator (lysosomal enzyme)
and to increase activity of myelo peroxide enzyme
and catalase in psoriasis patient compare to normal
individual.20 In psoriasis the main effect of high Li
level might influence inflammation through
granulocyte pathway not from lymphocyte. This
was proved by the increased proliferation and
decreased bactericide capacity of granulocyte but
not influence lymphocyte function. This research
was performed in PBMC normal individual
therefore need to be proof in psoriasis patient.21
The serum Mn level of psoriasis patient
describes manganese superoxide dismutase activity
that play role in cell differentiation and proliferation.15
This was proved with increase expression of mRNA
manganese superoxide dismutase in psoriasis skin
lesion.22 Mitogenesis in lymphocyte T cell could be
blockade by adding of 100 µmol/L Mn for 4-6
hours.23 In this research the smaller concentration
of Mn was used which was 0.02-0.08 µmol/L with
longer evaluation time which was 3 days.
Based on positive result of climatotherapy in
psoriasis patient that physical effect of bathing in
Dead Sea salt water will increase desquamation
effect and skin hydration, thus could increase
penetration of UV into the skin, immunomodulation
effect, anti inflammation effect and anti proliferation
effect cause by high mineral level, releasing
inflammatory mediators like leukocyte elastase and
cytokine.12,14 Therefore, beside in vitro effect to
PBMC also need to consider the clinical effect of
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bathing in Dead Sea salt water for the successful of
Balneophototherapy in psoriasis.
CONCLUSION
Mangan and Li in this research were proved
not significantly influence the viability of PBMC in
low dose (sub MED) and the viability tends to
decrease at doses 2 MED of NB-UVB exposure.
Therefore, it was suspected that Mn and Li level
was not an obstacle projector for psoriasis healing
process. Further research is really needed to know
the influences of Mn and Li concentration which
higher in psoriasis patient serum and influences of
Mn and Li to other cell which also play role in
psoriasis pathogenesis, like dendritic cell, fibroblast,
macrophage and keratinocyte cell.
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